Welcome to the Precipio Second Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements as these statements are based upon our current expectations, forecasts and assumptions, and are subject to significant risks and uncertainties. These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, believe, estimate, predict, potential, forecast, continue or the negative of these terms or other words or terms of similar meaning. Risks and uncertainties that could cause our actual results to differ materially from those set forth in any forward-looking statements include, but are not limited to, the matters listed under Risk Factors in our annual report on Form 10-K for the year ended December 30, 2022, which is on file with the Securities and Exchange Commission as well as other risks detailed in our subsequent filings with the Securities and Exchange Commission. These reports are available at www.sec.gov. Statements and information including forward-looking statements speak only to the date they are provided, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any statements or information including forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Now let me hand the call over to Ilan Danieli, Precipio's CEO. Please go ahead.

Thank you, and good afternoon. And thanks for joining our Q2 2023 shareholder update call. Now that you've had a chance to review our quarterly results, as well as see our recent press releases on revenues, growth, and our cost savings initiatives, I'd like to provide a bit more color as to where we stand midyear and some of the initiatives we are working towards. Our main goal for 2023 is to reach breakeven and financial independence. That means we will no longer need to raise capital to cover cash burn. We roll these vehicles such as the ATM, we can eliminate all the structures that create an overhang on the stock. We are fully aware of the fact that the biggest weight on our share price is the risk of the company needing to raise more capital, creating further dilution to shareholders. That's why management is laser-focused on two things and two things only. Revenue growth and cash burn reduction. So today, I'd like to spend some time on both of those aspects to give you a bit more of a flavor beyond the recent reports and press releases. Let's start with revenue growth. As you know, we have two revenue generating divisions, our Pathology Services Division and our Products Division. For the Pathology Services Division, let's start with the goals, which are very simple. Given our case mix, average revenue per unit and gross margin, the breakeven point for the division is approximately $14 million annual run rate, which translates into $3.5 million per quarter or a little under 1.2 million per month. In Q3, we did $2.7 million in revenues or 77% of that goal. However, in July, for the first time in the company history, we exceeded $1 million and we are at about 85% of…

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.